| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 7, 2003
From the Divisions of Gastroenterology and Nutrition (B.M.K., D.A.P.) and Human Genetics and Molecular Biology (N.B.S., I.D.K.), The Children’s Hospital of Philadelphia and The University of Pennsylvania School of Medicine, Philadelphia, Pa; the Division of Gastroenterology and Nutrition, Northwestern University Medical School, Children’s Memorial Hospital, Chicago, Ill (K.M.E.); Children’s Hospital and University of Manitoba, Winnipeg, Canada (A.E.C.); and Lutheran General Children’s Hospital, Park Ridge, Ill (C.B.). * To whom correspondence should be addressed. E-mail: ian2{at}mail.med.upenn.edu.
Background--Alagille syndrome (AGS) is a dominantly inherited multisystem disorder involving the liver, heart, eyes, face, and skeleton, caused by mutations in Jagged1. Intracranial bleeding is a recognized complication and cause of mortality in AGS. There are multiple case reports of intracranial vessel abnormalities and other vascular anomalies in AGS. The objective of this study was to characterize the nature and spectrum of vascular anomalies in AGS. Methods and Results--Retrospective chart review of 268 individuals with AGS was performed. Twenty-five patients (9%) had noncardiac vascular anomalies or events. Sixteen patients had documented structural vascular abnormalities. Two had basilar artery aneurysms, 7 had internal carotid artery anomalies, and another had a middle cerebral artery aneurysm. Moyamoya disease was described in 1 patient. Three of the 16 patients had aortic aneurysms, and 2 had aortic coarctations. One of the patients with a basilar artery aneurysm also had coarctation of the aorta. One of the individuals with an internal carotid artery anomaly also had renal artery stenosis. Nine more patients had intracranial events without documented vessel abnormalities. Vascular accidents accounted for 34% of the mortality in this cohort. Conclusions--The vascular anomalies described in our cohort of AGS individuals identify an underrecognized and potentially devastating complication of this disorder. It is a major cause of morbidity and mortality in this population, accounting for 34% of the mortality. We have also reviewed the body of evidence supporting a role for Jagged1 and the Notch signaling pathway in vascular development.
Revised on December 10, 2003
Accepted on January 5, 2004
Vascular Anomalies in Alagille Syndrome. A Significant Cause of Morbidity and Mortality
Binita M. Kamath MBBChir,
This article has been cited by other articles:
![]() |
D. Morrow, S. Guha, C. Sweeney, Y. Birney, T. Walshe, C. O'Brien, D. Walls, E. M. Redmond, and P. A. Cahill Notch and Vascular Smooth Muscle Cell Phenotype Circ. Res., December 5, 2008; 103(12): 1370 - 1382. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niessen and A. Karsan Notch Signaling in Cardiac Development Circ. Res., May 23, 2008; 102(10): 1169 - 1181. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. High, M. M. Lu, W. S. Pear, K. M. Loomes, K. H. Kaestner, and J. A. Epstein Endothelial expression of the Notch ligand Jagged1 is required for vascular smooth muscle development PNAS, February 12, 2008; 105(6): 1955 - 1959. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Niessen and A. Karsan Notch signaling in the developing cardiovascular system Am J Physiol Cell Physiol, July 1, 2007; 293(1): C1 - C11. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Hofmann and M. L. Iruela-Arispe Notch Signaling in Blood Vessels: Who Is Talking to Whom About What? Circ. Res., June 8, 2007; 100(11): 1556 - 1568. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Blue, J. M. Mah, A. D. Cole, V. Lal, M. J. Wilson, R. B. Chard, G. F. Sholler, R. E. Hawker, M. C. Sherwood, and D. S. Winlaw The negative impact of Alagille syndrome on survival of infants with pulmonary atresia J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1094 - 1096. [Full Text] [PDF] |
||||
![]() |
S. A. Stowell and J. Kitajewski Hey, There's a Hole in My Heart Circ. Res., March 30, 2007; 100(6): 764 - 765. [Full Text] [PDF] |
||||
![]() |
V. Agarwal, I. Ramnarine, A. F. Corno, and M. Pozzi Recurrent coarctation in a patient with Alagille syndrome Interactive CardioVascular and Thoracic Surgery, December 1, 2005; 4(6): 514 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Proweller, W. S. Pear, and M. S. Parmacek Notch Signaling Represses Myocardin-induced Smooth Muscle Cell Differentiation J. Biol. Chem., March 11, 2005; 280(10): 8994 - 9004. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadchouel, B. M. Kamath, N. B. Spinner, D. A. Piccoli, I. D. Krantz, K. M. Emerick, A. E. Chudley, and C. Booth Vascular Anomalies in Alagille Syndrome * Response Circulation, September 28, 2004; 110(13): e327 - e327. [Full Text] [PDF] |
||||
![]() |
J.-C. Tille and M.S. Pepper Hereditary Vascular Anomalies: New Insights Into Their Pathogenesis Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1578 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Baldwin Only Our Patients Know for Sure Circ. Res., June 11, 2004; 94(11): 1401 - 1402. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |